SkinBiotix Technology Generates Positive Data in First Two Elements of its Human Study

SkinBiotix Technology Generates Positive Data in First Two Elements of its Human Study

Source: 
CP Wire
snippet: 

SkinBioTherapeutics plc (AIM: SBTX) announced on 11/7/18 positive data from the first two elements of its human study which focus on skin irritancy and moisturisation potential.